UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreMultiple Myeloma: Stem Cell Transplant and Beyond
Presenter: Frits van Rhee MD, PhD, Professor of Medicine and Clinical Director of the UAMS Myeloma Center, University of Arkansas for Medical Sciences
Watch VideoMyeloma Center: First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well
Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.
News & Announcements
Pioneering Researcher Returns to UAMS Myeloma Center
John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…
Read more
UAMS Raises $15 Million Toward NCI Designation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it has raised more than $15 million towards NCI Designation, the halfway point toward its $30 million goal.
Read more
Be a Part of the Cure Telethon Raises $400,000
The 2nd annual Be a Part of the Cure Telethon to benefit the UAMS Winthrop P. Rockefeller Cancer Institute’s research and treatment programs raised nearly $400,000 despite a second year of pandemic challenges. “Cancer has affected us all, and the Winthrop P. Rockefeller Cancer Institute continues to see patients, provide treatment and take care of…
Read more
UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8
Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…
Read moreWant to read more stories like these?